Across TCGA pan-cancer cohorts, TRAJ58 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TRAJ58’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where TRAJ58 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRAJ58 is over-expressed in tumor.
LUAD and KIRC are the cancer types where TRAJ58 tumor–normal differential expression is most reproducible.